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The endocrine pancreas contains multiple cell types co-localized into clusters called the islets of 
Langerhans. The predominant cell types include alpha and beta cells, which produce glucagon and 
insulin, respectively. The regulated release of these hormones maintains whole body glucose 
homeostasis, essential to prevent complications from diabetes (e.g. blindness, kidney failure, and 
cardiovascular disease). In type 1 diabetes, an autoimmune reaction destroys the beta cells and patients 
must monitor their blood sugar levels and inject insulin in order to maintain euglycemia. In type 2 
diabetes, the beta cells fail to produce sufficient insulin to overcome the individual’s decreased insulin 
sensitivity. Most studies to date have focused on whole islets, which are very heterogeneous.  Recent 
focus has shifted to studying the individual islet cell subsets (i.e. alpha, beta, delta, PP, and other cell 
types). Unlike immunological cells, surface molecule reagents do not yet exist to specifically distinguish 
beta from alpha cells. We have successfully isolated pure populations of insulin producing beta cells and 
glucagon producing alpha cells by using intracellular hormone staining and fluorescence activated cell 
sorting. We present data that describe the ratio of beta cells to alpha cells across gender, age, and BMI. 
Further, we have characterized the miRNA profiles of alpha and beta cells and have begun to investigate 
the unique gene expression patterns of the two cell types. By developing the ability to profile multiple 
characteristics of alpha and beta cells, we hope to determine how gene, miRNA, and protein profiles 
change under environmental conditions that lead to beta cell failure, and others that may promote beta 
cell health or stimulate beta cell growth and proliferation. 
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